Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
198 Cards in this Set
- Front
- Back
ACM - 10
|
Appropriate Care Measures - 10
|
|
ACM - Complete
|
Appropriate Care Measures - Complete
|
|
ACM - Total
|
Appropriate Care Measures - Total
|
|
AMI - 1
|
Aspirin at arrival
|
|
AMI - 10
|
Statin Prescribed at Discharge
|
|
AMI - 2
|
Aspirin prescribed at discharge
|
|
AMI - 3
|
ACEI or ARB for LVSD
|
|
AMI - 5
|
Beta blocker prescribed at discharge
|
|
AMI - 7
|
Reperfusion therapy - Median time from arrival to initiation of fibrinolytic medication administration
|
|
AMI - 7a
|
Fibrinolytic Therapy Agent Received Within 30 Minutes of Hospital Arrival
|
|
AMI - 8
|
Reperfusion therapy - Median time from arrival to initiation of primary percutaneous transluminal coronary angioplasty
|
|
AMI - 8a
|
PCI received within 90 minutes of hospital arrival
|
|
CAC - 1a
|
Relievers for Inpatient Asthma (age 2 years through 17 years) - Overall Rate
|
|
CAC - 1b
|
Relievers for Inpatient Asthma (age 2 years through 4 years)
|
|
CAC - 1c
|
Relievers for Inpatient Asthma (age 5 years through 12 years)
|
|
CAC - 1d
|
Relievers for Inpatient Asthma (age 13 through 17 years)
|
|
CAC - 2a
|
Systemic Corticosteroids for Inpatient Asthma (age 2 years through 17 years) - Overall Rate
|
|
CAC - 2b
|
Systemic Corticosteroids for Inpatient Asthma (age 2 years through 4 years)
|
|
CAC - 2c
|
Systemic Corticosteroids for Inpatient Asthma (age 5 years through 12 years)
|
|
CAC - 2d
|
Systemic Corticosteroids for Inpatient Asthma (age 13 years through 17 years)
|
|
CAC - 3
|
Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver
|
|
ED-1a
|
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Overall Rate
|
|
ED-1b
|
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Reporting Measure
|
|
ED-1c
|
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Observation Patients
|
|
ED-1d
|
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Psychiatric/Mental Health Patients
|
|
ED-2a
|
Admit Decision Time to ED Departure Time for Admitted Patients - Overall Rate
|
|
ED-2b
|
Admit Decision Time to ED Departure Time for Admitted Patients - Reporting Measure
|
|
ED-2c
|
Admit Decision Time to ED Departure Time for Admitted Patients -Psychiatric/Mental Health Patients
|
|
HBIPS-1a
|
Admission Screening- Overall Rate
|
|
HBIPS-1b
|
Admission Screening- Children (1 through 12 years)
|
|
HBIPS-1c
|
Admission Screening- Adolescent (13 through 17 years)
|
|
HBIPS-1d
|
Admission Screening- Adult (18 through 64 years)
|
|
HBIPS-1e
|
Admission Screening- Older Adult (>=65 years)
|
|
HBIPS-2a
|
Physical Restraint- Overall Rate
|
|
HBIPS-2b
|
Physical Restraint- Children (1 through 12 years)
|
|
HBIPS-2c
|
Physical Restraint- Adolescent (13 through 17 years)
|
|
HBIPS-2d
|
Physical Restraint- Adult (18 through 64 years)
|
|
HBIPS-2e
|
Physical Restraint- Older Adult (>=65 years)
|
|
HBIPS-3a
|
Seclusion- Overall Rate
|
|
HBIPS-3b
|
Seclusion- Children (1 through 12 years)
|
|
HBIPS-3c
|
Seclusion- Adolescent (13 through 17 years)
|
|
HBIPS-3d
|
Seclusion- Adult (18 through 64 years)
|
|
HBIPS-3e
|
Seclusion- Older Adult (>=65 years)
|
|
HBIPS-4a
|
Multiple Antipsychotic Medications at Discharge- Overall Rate
|
|
HBIPS-4b
|
Multiple Antipsychotic Medications at Discharge- Children (1 through 12 years)
|
|
HBIPS-4c
|
Multiple Antipsychotic Medications at Discharge- Adolescent (13 through 17 years)
|
|
HBIPS-4d
|
Multiple Antipsychotic Medications at Discharge- Adult (18 through 64 years)
|
|
HBIPS-4e
|
Multiple Antipsychotic Medications at Discharge- Older Adult (>=65 years)
|
|
HBIPS-5a
|
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Overall Rate
|
|
HBIPS-5b
|
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Children (1 through 12 years)
|
|
HBIPS-5c
|
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Adolescent (13 through 17 years)
|
|
HBIPS-5d
|
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Adult (18 through 64 years)
|
|
HBIPS-5e
|
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Older Adult (>=65 years)
|
|
HBIPS-6a
|
Post Discharge Continuing Care Plan- Overall Rate
|
|
HBIPS-6b
|
Post Discharge Continuing Care Plan- Children (1 through 12 years)
|
|
HBIPS-6c
|
Post Discharge Continuing Care Plan- Adolescent (13 through 17 years)
|
|
HBIPS-6d
|
Post Discharge Continuing Care Plan- Adult (18 through 64 years)
|
|
HBIPS-6e
|
Post Discharge Continuing Care Plan- Older Adult (>=65 years)
|
|
HBIPS-7a
|
Post Discharge Continuing Care Plan Transmitted- Overall Rate
|
|
HBIPS-7b
|
Post Discharge Continuing Care Plan Transmitted - Children (1 through 12 years)
|
|
HBIPS-7c
|
Post Discharge Continuing Care Plan Transmitted - Adolescent (13 through 17 years)
|
|
HBIPS-7d
|
Post Discharge Continuing Care Plan Transmitted - Adult (18 through 64 years)
|
|
HBIPS-7e
|
Post Discharge Continuing Care Plan Transmitted - Older Adult (>=65 years)
|
|
HF - 1
|
Discharge Instructions
|
|
HF - 2
|
Evaluation of LVS Function
|
|
HF - 3
|
ACEI or ARB for LVSD
|
|
IMM-1a
|
Pneumococcal Immunization (PPV23) - Overall Rate
|
|
IMM-1b
|
Pneumococcal Immunization (PPV23) - Age 65 and Older
|
|
IMM-1c
|
Pneumococcal Immunization (PPV23) - High Risk Populations (Age 6 through 64 years)
|
|
IMM-2
|
Influenza Immunization
|
|
OP-1
|
Median Time to Fibrinolysis
|
|
OP-16
|
Troponin Results for ED AMI or ED CP Patients
|
|
OP-18
|
Median Time from ED Arrival to ED Departure for Discharged ED Patients
|
|
OP-18a
|
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Overall Rate
|
|
OP-18b
|
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Reporting Measure
|
|
OP-18c
|
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Observation Patients
|
|
OP-18d
|
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Psychiatric/Mental Health Patients
|
|
OP-18e
|
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Transfer Patients
|
|
OP-19
|
Transition Record with Specified Elements Received by Discharged Patients
|
|
OP-2
|
Fibrinolytic Therapy Received Within 30 Minutes of ED Arrival
|
|
OP-20
|
Door to Diagnostic Evaluation by a Qualified Medical Personnel
|
|
OP-21
|
Hospital Outpatient Pain Management Population
|
|
OP-23
|
Head CT or MRI Scan Results for Acute Ischemic Stroke or Hemorrhagic Stroke
|
|
OP-3a
|
Median Time to Transfer to Another Facility for Acute Coronary Intervention - Overall Rate
|
|
OP-3b
|
Median Time to Transfer to Another Facility for Acute Coronary Intervention - Reporting Measure
|
|
OP-3c
|
Median Time to Transfer to Another Facility for Acute Coronary Intervention - Quality Measure
|
|
OP-4
|
Aspirin at Arrival
|
|
OP-4b
|
Aspirin at Arrival - AMI
|
|
OP-4c
|
Aspirin at Arrival - Chest Pain
|
|
OP-5
|
Median Time to ECG
|
|
OP-5b
|
Median Time to ECG - AMI
|
|
OP-5c
|
Median Time to ECG - Chest Pain
|
|
OP-6
|
Timing of Antibiotic Prophylaxis
|
|
OP-7
|
Prophylactic Antibiotic Selection for Surgical Patients
|
|
PC - AMI
|
Perfect Care - AMI
|
|
PC - CAC
|
Perfect Care - CAC
|
|
PC - HBIPS
|
Perfect Care - HBIPS
|
|
PC - HF
|
Perfect Care - HF
|
|
PC - IMM
|
Perfect Care - Immunization
|
|
PC - PCB
|
Perfect Care - PC B
|
|
PC - PCM
|
Perfect Care - PC M
|
|
PC - PN
|
Perfect Care - PN
|
|
PC - SCIP
|
Perfect Care - SCIP
|
|
PC - STK
|
Perfect Care - STK
|
|
PC - VTE
|
Perfect Care - VTE
|
|
PC-OP AMI
|
Perfect Care - OP AMI
|
|
PC-OP CP
|
Perfect Care - OP CP
|
|
PC-OP ED
|
Perfect Care - OP ED
|
|
PC-OP STK
|
Perfect Care - OP STK
|
|
PC-OP Surgical
|
Perfect Care - OP Surgical
|
|
PCB-04
|
Health Care-Associated BSI in Newborns
|
|
PCB-05
|
Exclusive Breast Milk Feeding
|
|
PCM-01
|
Elective Delivery
|
|
PCM-02a
|
Cesarean Section
|
|
PCM-02b
|
Cesarean Section - 8 through 14 years
|
|
PCM-02c
|
Cesarean Section - 15 through 19 years
|
|
PCM-02d
|
Cesarean Section - 20 through 24 years
|
|
PCM-02e
|
Cesarean Section - 25 through 29 years
|
|
PCM-02f
|
Cesarean Section - 30 through 34 years
|
|
PCM-02g
|
Cesarean Section - 35 through 39 years
|
|
PCM-02h
|
Cesarean Section - 40 through 44 years
|
|
PCM-02i
|
Cesarean Section - 45 through 64 years
|
|
PCM-03
|
Antenatal Steroids
|
|
PN - 3a
|
Blood Cultures Performed Within 24 Hours Prior to or 24 Hours After Hospital Arrival for Patients Who Were Transferred or Admitted to the ICU Within 24 Hours of Hospital Arrival
|
|
PN - 3b
|
Blood Culture in Emergency Department Before First Antibiotic
|
|
PN - 6
|
Initial Antibiotic Selection for CAP in Immunocompetent Patient
|
|
PN - 6a
|
Initial Antibiotic Selection for CAP in Immunocompetent - ICU Patient
|
|
PN - 6b
|
Initial Antibiotic Selection for CAP Immunocompetent - Non ICU Patient
|
|
SCIP-Card-2
|
Patients on Beta Blockers PTA Who Received Beta Blockers Perioperatively
|
|
SCIP-Inf - 10
|
Surgery Patients with Perioperative Temperature Management
|
|
SCIP-Inf - 1a
|
Prophylactic Antibiotic Start Within 1 Hour - Overall Rate
|
|
SCIP-Inf - 1b
|
Prophylactic Antibiotic Start Within 1 Hour - CABG
|
|
SCIP-Inf - 1c
|
Prophylactic Antibiotic Start Within 1 Hour - Other Cardiac Surgery
|
|
SCIP-Inf - 1d
|
Prophylactic Antibiotic Start Within 1 Hour - Hip Arthroplasty
|
|
SCIP-Inf - 1e
|
Prophylactic Antibiotic Start Within 1 Hour - Knee Arthroplasty
|
|
SCIP-Inf - 1f
|
Prophylactic Antibiotic Start Within 1 Hour - Colon Surgery
|
|
SCIP-Inf - 1g
|
Prophylactic Antibiotic Start Within 1 Hour - Hysterectomy
|
|
SCIP-Inf - 1h
|
Prophylactic Antibiotic Start Within 1 Hour - Vascular Surgery
|
|
SCIP-Inf - 2a
|
Prophylactic Antibiotic Selection for Surgical Patients - Overall Rate
|
|
SCIP-Inf - 2b
|
Prophylactic Antibiotic Selection for Surgical Patients - CABG
|
|
SCIP-Inf - 2c
|
Prophylactic Antibiotic Selection for Surgical Patients - Other Cardiac Surgery
|
|
SCIP-Inf - 2d
|
Prophylactic Antibiotic Selection for Surgical Patients - Hip Arthroplasty
|
|
SCIP-Inf - 2e
|
Prophylactic Antibiotic Selection for Surgical Patients - Knee Arthroplasty
|
|
SCIP-Inf - 2f
|
Prophylactic Antibiotic Selection for Surgical Patients - Colon Surgery
|
|
SCIP-Inf - 2g
|
Prophylactic Antibiotic Selection for Surgical Patients - Hysterectomy
|
|
SCIP-Inf - 2h
|
Prophylactic Antibiotic Selection for Surgical Patients - Vascular Surgery
|
|
SCIP-Inf - 3a
|
Prophylactic Antibiotics End Within 24 Hours - Overall Rate
|
|
SCIP-Inf - 3b
|
Prophylactic Antibiotics End Within 48 Hours - CABG
|
|
SCIP-Inf - 3c
|
Prophylactic Antibiotics End Within 48 Hours - Other Cardiac Surgery
|
|
SCIP-Inf - 3d
|
Prophylactic Antibiotics End Within 24 Hours - Hip Arthroplasty
|
|
SCIP-Inf - 3e
|
Prophylactic Antibiotics End Within 24 Hours - Knee Arthroplasty
|
|
SCIP-Inf - 3f
|
Prophylactic Antibiotics End Within 24 Hours - Colon Surgery
|
|
SCIP-Inf - 3g
|
Prophylactic Antibiotics End Within 24 Hours - Hysterectomy
|
|
SCIP-Inf - 3h
|
Prophylactic Antibiotics End Within 24 Hours - Vascular Surgery
|
|
SCIP-Inf - 4
|
Cardiac Surgery Patients with Controlled Postoperative Glucose
|
|
SCIP-Inf - 6
|
Surgery Patients with Appropriate Hair Removal
|
|
SCIP-Inf - 9
|
Patients with urinary catheter removed on POD1 or POD2
|
|
SCIP-VTE-1
|
Patients with Recommended VTE Prophylaxis Ordered
|
|
SCIP-VTE-2
|
Patients Receiving VTE Prophylaxis within 24 Hours Prior to or After Surgery
|
|
STK-1
|
Venous Thromboembolism (VTE) Prophylaxis
|
|
STK-10
|
Assessed for Rehabilitation
|
|
STK-2
|
Discharged on Antithrombotic Therapy
|
|
STK-3
|
Anticoagulation Therapy for Atrial Fibrillation/Flutter
|
|
STK-4
|
Thrombolytic Therapy
|
|
STK-5
|
Antithrombotic Therapy By End of Hospital Day 2
|
|
STK-6
|
Discharged on Statin Medication
|
|
STK-8
|
Stroke Education
|
|
SUB ICD-9
|
Substance Abuse ICD-9 Population
|
|
SUB-1
|
Alcohol Use Screening
|
|
SUB-2
|
Alcohol Use Brief Intervention Provided or Offered
|
|
SUB-2a
|
Alcohol Use Brief Intervention
|
|
SUB-3
|
Alcohol and Other Drug Use Disorder Treatment Provided or Offered at Discharge
|
|
SUB-3a
|
Alcohol and Other Drug Use Disorder Treatment at Discharge
|
|
SUB-4
|
Alcohol and Drug Use: Assessing Status After Discharge
|
|
TOB ICD-9
|
Tobacco Use ICD-9 Population
|
|
TOB-1
|
Tobacco Use Screening
|
|
TOB-2
|
Tobacco Use Treatment Provided or Offered
|
|
TOB-2a
|
Tobacco Use Treatment
|
|
TOB-3
|
Tobacco Use Treatment Provided or Offered at Discharge
|
|
TOB-3a
|
Tobacco Use Treatment at Discharge
|
|
TOB-4
|
Tobacco Use: Assessing Status after Discharge
|
|
VTE-1
|
Venous Thromboembolism Prophylaxis
|
|
VTE-2
|
Intensive Care Unit Venous Thromboembolism Prophylaxis
|
|
VTE-3
|
Venous Thromboembolism Patients with Anticoagulation Overlap Therapy
|
|
VTE-4
|
Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol
|
|
VTE-5
|
Venous Thromboembolism Discharge Instructions
|
|
VTE-6
|
Incidence of Potentially-Preventable Venous Thromboembolism
|
|
AHRQ
|
Agency for Healthcare Research and Quality
|
|
AMI
|
Acute Myocardial Infarction
|
|
CAC
|
Children’s Asthma Care
|
|
ED
|
Emergency Department
|
|
HBIPS
|
Hospital-Based Inpatient Psychiatric Services
|
|
HF
|
Heart Failure
|
|
MIF
|
Measure Information Form
|
|
PN
|
Pneumonia
|
|
SCIP
|
Surgical Care Improvement Project
|
|
STK
|
Stroke
|
|
VTE
|
Venous Thromboembolism
|